RESTORATION OF BIOMARKER LEVELS IN ISCHEMIC STROKE

Abstract

Patients with ischemic stroke and low levels of PLA2G2A, DGLA, PADI4 biomarkers have a more severe course of the disease, manifested by an aggravation of neurological deficits and requiring longer treatment. Studies have shown that the inclusion in the complex rehabilitation of such patients of the nootropic drug oxiracetam and a product containing GLA, as well as the anticoagulant rivaroxaban in addition to standard therapy, contributes to a faster recovery compared with patients who received only standard treatment.